Goal Attainment Scaling in Upper Limb Spasticity Treatment

Recruiting N/A Interventional Study
Ischemic Stroke Hemorrhagic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
70 (estimated)
Sponsor
University Rehabilitation Institute, Republic of Slovenia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * patient's or caregiver's approval * ischemic or hemorrhagic stroke diagnosed using head CT/MRI * at least one upper limb muscle spasticity (MAS ≥ 3) * candidate for BTX-A treatment or already given BTX-A in the past * patient's or caregiver's capability for goal attainment pro…
Contacts

Metka Moharić, MD, PhD

+386 1 4758441

metka.moharic@ir-rs.si

CONTACT